← Eichor
Study identifier: NCT04689048 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery

Condition: Brain Metastases, Adult · Brain Metastases · Brain Cancer  ·  Sponsor: Baptist Health South Florida

PhasePhase 1
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The spread of cancer to the brain is referred to as brain metastases. Brain metastases are a common complication of cancer. This study is being done to determine whether the use of a new imaging agent, 18F-fluciclovine, is able to detect which patients are responding to radiation therapy. In addition, this study will look at the changes of the treated brain metastases using this imaging agent over time.

This description comes directly from the study's public registry record.

Talk to the study team

Rupesh C Kotecha, MD  ·  17865962000  ·  rupeshk@baptisthealth.net

Kristy Reyes  ·  786-524-7311  ·  Kristina.Reyes@baptisthealth.net

Always discuss trial participation with your own doctor first.

Locations (1)

Miami Cancer InstituteMiami, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04689048